Dissolving the self: Active inference, psychedelics, and ego-dissolution
The paper presents an active inference account of psychedelic-induced ego-dissolution, arguing that psychedelics lower precision on high-level priors (raising the Bayesian learning rate) which collapses the temporal thickness of the deep generative model and thereby dissolves the self-model. This framework links ego-dissolution to mechanisms underlying ordinary self-consciousness and its disturbances in conditions such as psychosis, autism, depression and dissociative disorders.
Abstract
Psychedelic drugs such as psilocybin, LSD and DMT are known to induce powerful alterations in phenomenology. Perhaps of most philosophical and scientific interest is their capacity to disrupt and even “dissolve” one of the most primary features of normal experience: that of being a self. Such “peak” or “mystical” experiences are of increasing interest for their potentially transformative therapeutic value. While empirical research is underway, a theoretical conception of the mechanisms underpinning these experiences remains elusive. In the following paper, psychedelic-induced ego-dissolution is accounted for within an active inference framework, as a collapse in the “temporal thickness” of an agent’s deep temporal model, as a result of lowered precision on high-level priors. The argument here is composed of three moves: first, a view of the self-model is proposed as arising within a temporally deep generative model of an embodied organism navigating an affordance landscape in the service of allostasis. Next, a view of the action of psychedelics as lowering the precision of high-level priors within the generative model is unpacked in terms of a high Bayesian learning rate. Finally, the relaxation of high-level priors is argued to cause a “collapse” in the temporal thickness of the generative model, resulting in a collapse in the self-model and a loss of the ordinary sense of being a self. This account has implications for our understanding of ordinary self-consciousness and disruptions in self-consciousness present in psychosis, autism, depression, and dissociative disorders. The philosophical, theoretical and therapeutic implications of this account are touched upon.
Research Summary of 'Dissolving the self: Active inference, psychedelics, and ego-dissolution'
Introduction
Psychedelic drugs such as psilocybin, LSD and DMT produce profound alterations in perception, emotion, time perception and self-consciousness, among which ego-dissolution (a felt loss of self or blurred self/world boundary) is especially noteworthy. Deane frames ego-dissolution as philosophically and therapeutically important yet mechanistically under-explained, noting prior suggestions that such experiences relate to relaxation of high-level beliefs within predictive processing frameworks and to measurable therapeutic outcomes when experienced as “peak” or mystical states. This paper sets out to provide a theoretical account of psychedelic-induced ego-dissolution within an active inference / predictive processing framework. Deane proposes three linked moves: (1) to characterise the self-model as arising from a temporally deep generative model that supports allostatic control; (2) to characterise the action of classical psychedelics as lowering the precision of high-level priors (operationalised as a very high Bayesian learning rate); and (3) to argue that reduced precision at high hierarchical levels collapses the temporal thickness of the generative model, producing the phenomenology of ego-dissolution. The account is intended to illuminate ordinary self-consciousness, pathological self-disruptions and therapeutic mechanisms.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Compounds
- Topics
- APA Citation
Deane, G. (2020). Dissolving the self: Active inference, psychedelics, and ego-dissolution. Philosophy and the Mind Sciences, 1(I), 1-27. https://doi.org/10.33735/phimisci.2020.I.39
References (27)
Papers cited by this study that are also in Blossom
Bayne, T., Carter, O. · Neuroscience of Consciousness (2018)
Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)
Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Carter, O. L., Hasler, F. ;., Pettigrew, J. D. et al. · Psychopharmacology (2007)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)
Kometer, M., Cahn, B. R., Andel, D. et al. · Biological Psychiatry (2011)
Show all 27 referencesShow fewer
Lebedev, A. V., L€ Ovd En, M., Rosenthal, G. et al. · Human Brain Mapping (2015)
Letheby, C., Gerrans, P. · Neuroscience of Consciousness (2017)
Ly, C., Greb, A. C., Cameron, L. P. et al. · Cell Reports (2018)
Lyons, T., Carhart-Harris, R. L. · Frontiers in Psychology (2018)
Millière, R. · Frontiers in Human Neuroscience (2017)
Milliere, R., Carhart-Harris, R. L., Roseman, L. et al. · Frontiers in Psychology (2018)
Moreno, F. A., Wiegand, C. B., Taitano, E. K. et al. · Journal of Clinical Psychiatry (2006)
Nour, M. R., Carhart-Harris, R. L. · British Journal of Psychiatry (2017)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Pink-Hashkes, S., Van Rooij, I., Kwisthout, J. · CogSci (2017)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Ramachandran, V., Chunharas, C., Marcus, Z. et al. · Neurocase (2018)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Scott, G., Carhart-Harris, R. L. · Neuroscience of Consciousness (2019)
Strassman, R. J. · Journal of Nervous and Mental Disease (1984)
Timmermann, C., Spriggs, M. J., Kaelen, M. et al. · Neuropharmacology (2018)
Cited By (2)
Papers in Blossom that reference this study
McAlpine, R., Kamboj, S. K. · Scientific Reports (2024)
Brasher, T., Rosen, D., Spinella, M. · International Journal of Wellbeing (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.